Netilmicin sulfate CAS:56391-57-2
Yawanci ana ba da maganin Netilmicin sulfate a ƙarƙashin kulawar likita a asibiti, musamman ga manyan cututtukan ƙwayoyin cuta inda aka nuna maganin parenteral. Masu ba da sabis na kiwon lafiya suna tantance adadin da ya dace da kuma yawan shan maganin bisa ga abubuwa kamar shekarun majiyyaci, nauyi, aikin koda, da kuma tsananin kamuwa da cutar. Yawanci ana ba da maganin ta hanyar jijiya ko ta hanyar jijiya a lokaci-lokaci don kiyaye matakan jinin magani. Kafin fara magani da netilmicin sulfate, masu ba da sabis na kiwon lafiya na iya yin gwajin kamuwa da cuta don tabbatar da ingancinsa akan takamaiman nau'in ƙwayoyin cuta da ke haifar da kamuwa da cuta. Yana da mahimmanci a bi umarnin da aka tsara da tsawon lokacin magani don cimma sakamako mafi kyau na magani da kuma rage haɗarin juriya ga maganin rigakafi. Ya kamata a sa ido sosai kan marasa lafiya da ke karɓar netilmicin sulfate don ganin duk wata alama ta mummunan sakamako, musamman gubar nephrotoxicity da ototoxicity, waɗanda ke da alaƙa da magungunan rigakafi na aminoglycoside. Ana iya ba da shawarar gwaje-gwajen aikin koda da kimanta ji yayin magani don gano duk wata matsala da za ta iya tasowa cikin sauri. Ajiyewa da sarrafa allurar netilmicin sulfate da kyau suna da mahimmanci don kiyaye kwanciyar hankali da ingancinsu. Ya kamata a adana maganin kamar yadda aka umarta daga masana'anta, nesa da haske da danshi, kuma a jefar da shi idan maganin ya canza launi ko ya ƙunshi barbashi. Shawarar ƙwararren ma'aikacin lafiya don samun jagora kan yadda ake amfani da kuma amfani da netilmicin sulfate yadda ya kamata don samun lafiya da ingantaccen magani ga cututtukan ƙwayoyin cuta.
| Tsarin aiki | C42H92N10O34S5 |
| Gwaji | 99% |
| Bayyanar | farin foda |
| Lambar CAS | 56391-57-2 |
| shiryawa | Ƙarami da girma |
| Rayuwar shiryayye | Shekaru 2 |
| Ajiya | A adana a wuri mai sanyi da bushewa |
| Takardar shaida | ISO. |







![tert-butyl 5-azaspiro[2.5]octan-8-ylcarbamate CAS:1232542-24-3](https://cdn.globalso.com/xindaobiotech/2QGOH2R49Y37X8W8E88O4D31.png)
